SourceBio International – proposed AIM cancellation and tender offer, why might there have been a lack of investor “attention”?
SourceBio International (SBI) has announced proposed cancellation of its, AIM, stock market listing and a “tender offer pursuant to which up to 11,071,810 ordinary shares (representing approximately 14.9 per cent. of the existing share capital of the company) would be purchased by the company at a price of 115 pence per ordinary share”. With the shares currently 110p and there 74,183,038 in issue, why is this proposed and what does it mean for shareholders?
- By Steve Moore
- 2022-11-23 16:09:59